Fee Schedule
Review Charges for Trials Supported by Pharmaceutical Firms and Other For-Profit Entities.
(Please note: There will continue to be NO CHARGE for federal, foundation, investigator-initiated, or university supported research.)
IRB Review Category |
|
Fee for Studies submitted for the July 17, 2008 meeting or after July 1, 2008 |
|
|
|
Full Board Review* |
|
$2,000 |
|
|
|
Expedited Review* |
|
$1,000 |
|
|
|
Annual Reviews |
|
$250 |
|
|
|
Revisions* |
|
|
Major Changes (full board review) |
|
$500 |
Minor changes (expedited review) |
|
No charge |
|
|
|
Exempt Status* |
|
$500 |
|
|
|
Recruitment Materials |
|
No charge |
|
|
|
Adverse Events |
|
No charge |
|
|
|
*Appropriateness of review category determined by the IRB office |
|
